Home › Steatotic Liver Disease › California › Sacramento
Steatotic Liver Disease clinical trials in Sacramento, CA
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Sacramento
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Sacramento
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RecruitingPhase 2
- GSK Investigational Site, Sacramento
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- Orlando, FL9 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer22 studies
- Breast Cancer20 studies
- Prostate Cancer19 studies
- Metastatic Cancer16 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Colon Cancer11 studies
- Bladder Cancer10 studies
- Colorectal Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.